BTMD - Company ID 0001819253
The table below shows biote Corp.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $3.90M | $6.47M | $7.37M | $12.99M | $6.97M | -$627.00K |
| Capital expenditure | $362.00K | $1.63M | $704.00K | $62.00K | $262.00K | - |
| Investing cash flow | -$1.17M | -$1.85M | -$12.18M | -$380.00K | -$482.00K | -$317.50M |
| Dividends paid | $405.00K | $694.00K | $83.00K |
biote Corp. reported operating cash flow of $35.19M for fiscal year 2025. That is down 22.2% from $45.24M in fiscal 2024. Over the 5 fiscal years shown, operating cash flow grew from $33.72M (FY 2021) to $35.19M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.09M |
| $2.73M |
| - |
| Stock buybacks | $1.07M | - | $4.09M | - | - | - |
| Financing cash flow | -$21.54M | -$2.26M | -$5.41M | -$4.24M | -$5.56M | $319.05M |